Mccormick & CO INC

McCormick & Company reported a 16.7% increase in second-quarter net sales and reaffirmed its full-year 2026 financial outlook.

McCormick & Company, Inc. announced the appointment of Cindy Hoots, former Chief Digital Officer and CIO of AstraZeneca PLC, to its Board of Directors, effective June 1, 2026.

McCormick & Company appoints Andrew Foust as Chief Integration Officer to lead the Unilever foods business combination.

McCormick & Company has entered into a definitive agreement to acquire Unilever's global foods business in a transaction valued at $15.7 billion.

McCormick & Company, Inc. held its Annual Meeting of Stockholders on April 1, 2026, where directors were elected, the appointment of Ernst & Young LLP as independent auditor was ratified, and executive compensation was approved in an advisory vote.

McCormick & Company reported strong first quarter 2026 financial results, driven by the McCormick de Mexico acquisition and organic growth, while reaffirming its full fiscal year 2026 outlook.

McCormick & Company reported 16.7% net sales growth in Q2 2026, driven by the consolidation of McCormick de Mexico and ongoing strategic integration efforts.

McCormick & Company reports strong first-quarter sales growth driven by acquisitions and favorable pricing, while announcing a transformative merger with Unilever's Foods business.

McCormick & Company reported a 2.7% increase in net sales for the third quarter of 2025, alongside a strategic acquisition to boost its ownership in McCormick de Mexico.

McCormick & Company reported a 1.0% increase in net sales for the second quarter of 2025, reaching $1,659.5 million, alongside a 5.0% rise in operating income, despite a significant increase in special charges and a higher effective tax rate.

McCormick & Company's first quarter 2025 net sales edged up 0.2% year-over-year, with currency fluctuations impacting overall growth.

McCormick & Company's third-quarter results show a slight sales decrease but improved profit margins driven by cost-saving initiatives.

McCormick & Company reported a 1.7% net sales increase in 2025, driven by volume and pricing, and projects 13-17% sales growth in 2026, significantly boosted by the McCormick de Mexico acquisition.

McCormick & Company's fiscal year 2024 saw modest sales growth and improved operating income, but the company anticipates a slower growth trajectory in 2025 due to currency headwinds and strategic investments.

McCormick & Company's 2023 annual report reveals a 4.9% increase in net sales, primarily due to pricing actions, alongside strategic cost management and investments in future growth.

Lawrence Erik Kurzius, a 10% owner of Mccormick & Co Inc, sold 205,538 shares of common stock on August 10, 2026 for $52.69 per share.

Sarah Piper, Chief Human Relations Officer of Mccormick & Co Inc, received 48 shares of common stock on August 10, 2026.

Sarah Piper, Chief Human Relations Officer of Mccormick & Co Inc, received 50 shares of common stock on July 30, 2026.

Brendan M Foley, Chairman, President & CEO and a Director of Mccormick & Co Inc, received 49 shares of common stock on July 30, 2026.

Michael Aaron Conway, a Director of Mccormick & Co Inc, purchased 1,100 shares of common stock on July 23, 2026 for $50.21 per share.

McCormick & Company, Inc. has announced the planned operating model, executive team, and secondary listing location for the combined company following its transaction with Unilever Foods, expected by mid-2027.

McCormick & Company, Incorporated has filed a definitive proxy statement with the SEC.

McCormick & Company will hold its 2025 Annual Meeting virtually on March 26, 2025, and has released details on director nominees and executive compensation for fiscal year 2024.

Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Inc., has amended his Schedule 13D filing to report transactions including the sale of 125,385 shares and the exercise and sale of 205,538 shares.

McCormick & Company's Chairman, President, and CEO, Brendan M. Foley, reported beneficial ownership of 5.1% of the company's Common Stock, primarily through equity compensation.

Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, reported an increased beneficial ownership of 11.8% of the company's common stock, including recent option exercises and sales.

Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Incorporated, has updated his beneficial ownership, reporting a 12.9% stake in the company's Common Stock.

Vanguard Capital Management has reported beneficial ownership of 19,099,707 shares, representing 7.53% of McCormick & Co Inc's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.47% of McCormick & Co. Inc.'s common stock as of March 31, 2026.

The Vanguard Group, Inc. has filed an amended Schedule 13G, reporting 0% beneficial ownership of McCormick & Co Inc/MD common stock following an internal corporate realignment.